US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist
  • 3.1899
  • -0.00010.00%
Trading Dec 13 12:45 ET
27.75MMarket Cap-5.50P/E (TTM)

Dare Bioscience Key Stats

Dare Bioscience Q3 2024 Earnings Date

Currency:USDNov 14, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
2.02M
41.69K
-1.98M
Miss Est.
+102.30%
-95.83%
-97.94%
EPS
-0.68
-0.55
+0.13
Beat Est.
+36.58%
+49.54%
+19.70%
Buy

Nov 30, 2024

Dare Bioscience Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 1.000M--
Nov 14, 20242024/Q341.690K / 2.023M--
Aug 12, 20242024/Q222.440K / 189.330K--
May 14, 20242024/Q19.300K / 260.500K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 1.000M--
Nov 14, 20242024/Q341.690K / 2.023M--
Aug 12, 20242024/Q222.440K / 189.330K--
May 14, 20242024/Q19.300K / 260.500K--

Unlock Free Earnings Estimates

Dare Bioscience Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data